Skip to main content

In a strategic move to reinforce its status as a global partner in the supply of surgical instruments, Oury Medical is delighted to announce the acquisitions of Metal Global Concept (MGC) and Imprint Medical. These acquisitions, which follow that of SMAO, reinforce the expansion strategy of the Oury Medical group orchestrated by TAG Partners (formerly SPE Capital Europe) since its investment in October 2022.

Oury Medical’s ambition is to support its orthopedic customers from the design phase through to mass production, with tailor-made, innovative solutions for all surgical instrumentation needs.

Acquisition of MGC

For over 40 years, MGC has supported its customers with its core expertise in precision sheet metal work for the medical sector, as well as the aerospace and paramedical segments. Since 2018, with the support of a new management team from the medical sector and thanks to its technical expertise in the production of metal housings, MGC has been developing a complete range of containers for the medical, dental and veterinary segments. These high-quality products can be found in major global markets such as the USA and Japan.

With this in mind, the acquisition of MGC represents a crucial step in the construction of the Oury Medical Group. By adding containers to its product range, Oury Medical intends to position itself as the preferred partner for surgical instrumentation.

Acquisition of Imprint Medical

Imprint Medical is a Lyon-based company renowned for its expertise in the research and development of surgical implants and instruments. While retaining its independence, Imprint Medical will now be able to draw on the production and prototyping capabilities of the Oury Medical group to better serve its customers.

For Oury Medical, this acquisition marks the creation of a fully-fledged R&D department, offering customers new opportunities for collaboration and co-development from the very first sketches of a new design.

These acquisitions are perfectly in line with TAG Partners’ strategy of creating value for its portfolio of SMEs, by bringing: i) operational transformation, ii) external growth synergies to improve positioning in the value chain and customer offering, and iii) an international dimension.

Management perspective

Christian Oury, President of Oury Medical, comments: “These acquisitions demonstrate our commitment to being the complete solutions provider in the field of surgical instruments, right from the design phase of new surgical techniques and associated instrumentation, thanks to Imprint Medical’s R&D capabilities. By integrating MGC’s innovative portfolio into our own, we are not only expanding our product range, but also raising the level of service and quality offered to our customers.”

Georges-Alexandre Ancenys, Managing Partner, TAG Partners (formerly SPE Capital Europe), comments: “As previously announced, following the acquisition of SMAO, we are delighted to continue to support the development of Oury Medical with these new strategic acquisitions, which enable the group to better meet the needs of its customers, by offering them a complete solution, from engineering to a complete set of instruments. We are delighted and honored to join forces with MGC, Imprint Medical and all their employees to write this new page in the history of the Oury Medical group.

These three acquisitions, made just one year after our investment in Oury Medical, complete a first cycle of acquisitions that gives Oury Medical the means to achieve its ambitions, while offering new opportunities for the Group’s employees to grow and attract new talent.”

About Oury Medical

Oury Medical is a century-old medical device company, member of the French Fab and labeled Entreprise du Patrimoine Vivant (E.P.V.). Founded in 1909 in Nogent, Haute-Marne, and strengthened by the Villiers-le-Sec site (SMAO), Oury Medical has established its position in the development and manufacture of orthopedic instrumentation and ancillary equipment. Oury Medical’s customers include some of the largest orthopedic groups in France.

About Metal Global Concept (MGC)

MGC has been based in Grenoble for over 40 years. MGC supports its customers in its core expertise of precision sheet metal work. Since 2018, MGC has been developing an industrial tool and organization focused on the development of containers for the medical segment.

About Imprint Medical

Imprint Medical is a company involved in the development of implants and instruments for the spine and orthopedics in general, having developed in-depth expertise in additive manufacturing.

About TAG Partners (formerly SPE Capital Europe)

TAG Partners, an investment company co-founded and managed by Georges-Alexandre Ancenys, Thierry Manceau and André Wagner, aims to invest in French SMEs with strong potential for transformation and growth. TAG’s founding partners apply their combined experience, know-how and energy to help portfolio SMEs reach their full potential. This support focuses on three main areas:

  • Operational transformation
  • External growth to improve positioning in the value chain and strengthen the product range
  • Activating levers for local and international growth

TAG systematically invites a pool of co-investors (entrepreneurs,
family offices, industry experts, etc.) to join each round of financing, to foster an open exchange of ideas and experience with the management of our portfolio companies.

TAG Partners is affiliated with SPE Capital, an independent investment company with over €500 million in assets under management, operating in the EMEA region.